Related Experiment Videos
Depressive symptoms associated with dexamethasone resistance.
Psychiatry Research
|November 1, 1983
Summary
Certain Hamilton Depression Rating Scale symptoms predict dexamethasone resistance or suppression in depressed outpatients. This finding aids in understanding treatment response markers for depression.
Area of Science:
- Psychiatry
- Neuroendocrinology
- Clinical Psychology
Background:
- The dexamethasone suppression test (DST) is a biological marker used in diagnosing and understanding depression.
- Identifying specific clinical symptoms associated with DST results can improve diagnostic accuracy and treatment prediction.
Purpose of the Study:
- To determine which items on the Hamilton Depression Rating Scale (HDRS) correlate with dexamethasone resistance and suppression in depressed outpatients.
- To assess the predictive accuracy of a classification function based on these HDRS items.
Main Methods:
- Split-sample discriminant function analysis was performed on data from 63 consecutive depressed outpatients.
- Specific HDRS items were analyzed for their association with dexamethasone resistance and suppression.
Main Results:
- Items such as late/middle insomnia, retardation, anxiety, and obsessive-compulsive symptoms were associated with dexamethasone resistance.
- Genital symptoms, somatic-general symptoms, hypochondriasis, early insomnia, and depersonalization were linked to dexamethasone suppression.
- The classification function achieved 100% accuracy on the index split sample, 84% on the overall sample, and 72% on the other split sample.
Conclusions:
- Specific clinical features of depression, as measured by the HDRS, can predict outcomes of the dexamethasone suppression test.
- These findings may offer valuable insights into the biological underpinnings of depression subtypes and inform clinical decision-making.